These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27101239)

  • 1. Advancements in Imaging Technology for Detection and Diagnosis of Palpable Breast Masses.
    Jaeger BM; Hong AS; Letter H; Odell MC
    Clin Obstet Gynecol; 2016 Jun; 59(2):336-50. PubMed ID: 27101239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
    Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
    Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
    Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective statistical analysis on the diagnostic value of ductography based on lesion pathology in patients presenting with nipple discharge.
    Srinivasan A; Nia E; Gupta M; Sun J; Leung JW
    Breast J; 2019 Jul; 25(4):585-589. PubMed ID: 31087380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
    Mirzaei S; Knoll P; Lipp RW; Köhn H
    J Nucl Med; 2000 Feb; 41(2):390-1. PubMed ID: 10688127
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique.
    Weigert JM; Bertrand ML; Lanzkowsky L; Stern LH; Kieper DA
    AJR Am J Roentgenol; 2012 Jan; 198(1):W69-75. PubMed ID: 22194518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is (99m)Tc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses?
    Alonso O; Massardo T; Delgado LB; Horvath J; Kabasakal L; Llamas-Olier A; Maunda KK; Morales R; Padhy AK; Shankar UR
    J Nucl Med; 2001 Nov; 42(11):1614-21. PubMed ID: 11696629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The difficult breast.
    Ziewacz JT; Neumann DP; Weiner RE
    Surg Oncol Clin N Am; 1999 Jan; 8(1):17-33. PubMed ID: 9824360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
    Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
    J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of Tc-99m-MIBI for breast carcinoma in correlation with mammography and sonography.
    Habib S; Maseeh-uz-Zaman ; Hameed A; Niaz K; Hashmi H; Kamal S
    J Coll Physicians Surg Pak; 2009 Oct; 19(10):622-6. PubMed ID: 19811712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of (99m)Tc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with X-rays mammography, ultrasonography and magnetic resonance imaging.
    Ozülker T; Ozülker F; Ozpaçaci T; Bender O; Değirmenci H
    Hell J Nucl Med; 2010; 13(2):144-9. PubMed ID: 20808988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing delay in the diagnosis of pregnancy-associated breast cancer: how imaging can help us.
    Taylor D; Lazberger J; Ives A; Wylie E; Saunders C
    J Med Imaging Radiat Oncol; 2011 Feb; 55(1):33-42. PubMed ID: 21382187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer detection with sestamibi-Tc-99m and Tl-201 radionuclides in patients with non conclusive mammography.
    Alonso JC; Soriano A; Zarca MA; Guerra P; Alcazar R; Molino C
    Anticancer Res; 1997; 17(3B):1661-5. PubMed ID: 9179214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast tumor localization using sestamibi.
    Coover LR; Malaspina PJ
    Clin Nucl Med; 2002 Mar; 27(3):161-4. PubMed ID: 11852300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of (99m)Tc- MIBI for breast carcinoma in correlation with mammography and sonography.
    Tunio MA
    J Coll Physicians Surg Pak; 2010 Apr; 20(4):289; author reply 289-90. PubMed ID: 20392413
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of MIBI breast scintigraphy in evaluation of palpable breast lesions.
    Lam WW; Yang WT; Chan YL; Stewart IE; King W; Metreweli C
    Br J Radiol; 1996 Dec; 69(828):1152-8. PubMed ID: 9135472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Scintimammography with 99mTC-MIBI in the clinical practice: repercussion on the clinical management of the patient].
    Prats E; Razola P; Sainz JM; Tardín L; Andrés A; Abós MD; García F; Fernández J; Villavieja L; Banzo J
    Rev Esp Med Nucl; 2007; 26(3):153-9. PubMed ID: 17524309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of early breast cancer: an overview and future prospects.
    Zhou XH; Gordon R
    Crit Rev Biomed Eng; 1989; 17(3):203-55. PubMed ID: 2673660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.